Abstract | AIM: PATIENTS AND METHODS: RESULTS: The 5-year survival rate was 77.5% considering all 66 patients, and 85.7%, 71.8%, and 78.8% for those with p-stage I, II, and III, respectively. Patients who received a matched chemotherapy regimen (n=13; platinum plus docetaxel in eight, platinum plus pemetrexed in five) had significantly better 5-year survival than patients with unmatched biomarker status (n=53) (100% vs. 71.0%, p=0.0011). CONCLUSION:
|
Authors | Dage Liu, Nariyasu Nakashima, Jun Nakano, Shintaro Tarumi, Natsumi Matsuura, Takayuki Nakano, Kazuhito Nii, Yoshimasa Tokunaga, Tetsuhiko Go, Hiroyasu Yokomise |
Journal | Anticancer research
(Anticancer Res)
Vol. 37
Issue 5
Pg. 2501-2507
(05 2017)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 28476819
(Publication Type: Journal Article)
|
Copyright | Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Biomarkers, Tumor
- DNA-Binding Proteins
- Drug Combinations
- Pyridines
- Taxoids
- Tubulin
- Tumor Suppressor Proteins
- tegafur-gimeracil-oteracil
- Pemetrexed
- Tegafur
- Docetaxel
- Oxonic Acid
- Carboplatin
- RRM1 protein, human
- Ribonucleoside Diphosphate Reductase
- TYMS protein, human
- Thymidylate Synthase
- ERCC1 protein, human
- Endonucleases
|
Topics |
- Adult
- Aged
- Antineoplastic Agents
(therapeutic use)
- Biomarkers, Tumor
(metabolism)
- Carboplatin
(therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, metabolism, surgery)
- Chemotherapy, Adjuvant
- DNA-Binding Proteins
(metabolism)
- Disease-Free Survival
- Docetaxel
- Drug Combinations
- Endonucleases
(metabolism)
- Female
- Humans
- Lung Neoplasms
(drug therapy, metabolism, surgery)
- Male
- Middle Aged
- Oxonic Acid
(therapeutic use)
- Pemetrexed
(therapeutic use)
- Pyridines
(therapeutic use)
- Ribonucleoside Diphosphate Reductase
- Taxoids
(therapeutic use)
- Tegafur
(therapeutic use)
- Thymidylate Synthase
(metabolism)
- Tubulin
(metabolism)
- Tumor Suppressor Proteins
(metabolism)
|